Flu Forum: Are You Ready for the 2019-2020 Season?

1.00 CME
1.00 AANP
60 MINS
$0 FEE
SAVE
Doctor checking woman's heart

Overview

Provider Statement

This continuing education activity is provided by Vindico Medical Education.


Support Statement

This activity is supported by an educational grant from Genentech, Inc.


Target Audience

The intended audience for the activity is internists, family practice physicians, nurse practitioners, physician assistants, pharmacists, and other health care professionals involved in the management of patients with influenza.


Learning Objectives

Upon successful completion of this activity, participants should be able to:

  • Review the use of diagnostic assays and their ability to detect influenza so that treatment can be applied earlier in the disease process.
  • Incorporate therapeutic regimens into practice for prophylaxis, prevention, and treatment of influenza to reduce the duration of illness, viral shedding, and complications associated with the disease.

Activity Co-Chairs

Michael G. Ison, MD, MS, FIDSA, FAST
Professor, Divisions of Infectious Diseases and Organ Transplantation
Northwestern University Feinberg School of Medicine
Medical Director, Transplant and Immunocompromised Host Infectious Diseases Service
Northwestern University Comprehensive Transplant Center
Chicago, IL

John J. Russell, MD
Clinical Professor of Family and Community Medicine 
Thomas Jefferson University 
Sidney Kimmel School of Medicine 
Philadelphia, PA
Chair, Department of Family Medicine
Program Director, Family Medicine Residency  
Abington – Jefferson Health
Abington, PA


Reviewers

Marilyn N. Bulloch, PharmD, BCPS, FCCM
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP 
Ronald A. Codario, Jr., MD 
Linda Giarraputo, PA-C


Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

ACPEVindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. 


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is acceptable for 1.0 contact hours of ACPE Continuing Education Credit. The ACPE Universal Program Number 0482-0000-19-005-H01-P, effective 10/4/2019. This is a knowledge-based activity and there is no fee to attend.

aanpThis activity is approved for 1.0 contact hour(s) of continuing education (which includes 0.75 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 19093891. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Image result for aapa logoThis activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid for one year from 10/04/2019. PAs should only claim credit commensurate with the extent of their participation.
Successful completion of the post-test is required to earn AAPA Category 1 CME credit. Successful completion is defined as a cumulative score of at least 70 percent correct.

Successful completion of this CME activity enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants who opt-in will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

This enduring material is approved for 1 year from the date of original release, October 4, 2019, to September 30, 2020.


How to Participate in This Activity and Obtain CE Credit

To participate in this CE activity, you must read the objectives, answer the pretest questions, review the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™, ACPE Statement of Credit, Learner-Paced Contact Hours certificate, or an AAPA Category 1 CME Certificate. Participants claiming CPE credit will be reported directly to CPE Monitor within 30 days of successful completion of the activity.


MIPS Qualifying Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Participants who successfully complete the activity and its performance assessment will receive printable documentation of successful completion for MIPS self-reporting.
To meet the criteria for improvement activities in the Merit-Based Incentive Payment System (MIPS) of QPP, accredited CME providers need to implement activities that:

  • address a quality or safety gap that is supported by a needs assessment or problem analysis, or support the completion of such a needs assessment as part of the activity;
  • have specific, measurable aim(s) for improvement;
  • include interventions intended to result in improvement;
  • include data collection and analysis of performance data to assess the impact of the interventions; and
  • define meaningful clinician participation in their activity, describe the mechanism for identifying clinicians who meet the requirements, and provide participant completion information.

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Faculty reports the following relationship(s)

Michael G. Ison, MD, MS, FIDSA, FAST
Royalty: UpToDate
Consulting Fee: Celltrion, Genentech/Roche, Janssen, Seqirus, Shionogi, Toyama/MediVector, VirBio
Contracted Research: Beckman Coulter, Cepheid, Chimerix, Emergent BioScience, Gilead, Janssen, Shire
Data Safety & Monitoring Board: GlaxoSmithKline, Shionogi

John J. Russell, MD
Consulting Fee: GlaxoSmithKline, Sanofi Pasteur 
Speakers Bureau: Sanofi Pasteur 

Reviewers report the following relationship(s)

Marilyn N. Bulloch, PharmD, BCPS, FCCM
Speakers Bureau: Genentech
Contributing Author: Pharmacy Times
Speaker Honoraria: CPNP, Pharmacy Times

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Ronald A. Codario, Jr.,  MD
No relevant financial relationships to disclose.

Linda A. Giarraputo, PA-C
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2019 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at cme@vindicoCME.com